
09/10/2023
The URV spin-off company Renalyse plans to industrialise its device for diagnosing chronic kidney disease
The company, also known as CreatSens Health, has raised 1,000,000 euros through public and private investment
The company, also known as CreatSens Health, has raised 1,000,000 euros through public and private investment
The Times Higher Education “Young University Ranking” places it in the 151-200 range in the list of 605 young universities in the world and reaffirms its excellence in teaching, research and knowledge transfer.
The company was partially founded by the URV and works on controlling the progress of chronic kidney disease by analysing biochemical parameters in the blood
at Technology Transfer and Innovation Centre